Submitted Successfully!
To reward your contribution, here is a gift for you: A free trial for our video production service.
Thank you for your contribution! You can also upload a video entry or images related to this topic.
Version Summary Created by Modification Content Size Created at Operation
1 format correction + 251 word(s) 251 2020-09-16 12:05:37 |
2 format correct -1 word(s) 250 2020-10-27 07:47:16 | |
3 entry type change Meta information modification 250 2020-11-06 15:04:11 |

Video Upload Options

Do you have a full video?


Are you sure to Delete?
If you have any further questions, please contact Encyclopedia Editorial Office.
Stafstrom, C.E.; Jantzie, L.L. COVID-19: Neurological Considerations in Neonates/Children. Encyclopedia. Available online: (accessed on 21 April 2024).
Stafstrom CE, Jantzie LL. COVID-19: Neurological Considerations in Neonates/Children. Encyclopedia. Available at: Accessed April 21, 2024.
Stafstrom, Carl E., Lauren L. Jantzie. "COVID-19: Neurological Considerations in Neonates/Children" Encyclopedia, (accessed April 21, 2024).
Stafstrom, C.E., & Jantzie, L.L. (2020, October 07). COVID-19: Neurological Considerations in Neonates/Children. In Encyclopedia.
Stafstrom, Carl E. and Lauren L. Jantzie. "COVID-19: Neurological Considerations in Neonates/Children." Encyclopedia. Web. 07 October, 2020.
COVID-19: Neurological Considerations in Neonates/Children

The ongoing worldwide pandemic of the novel human coronavirus SARS-CoV-2 and the ensuing disease, COVID-19, has presented enormous and unprecedented challenges for all medical specialists. However, to date, children, especially neonates, have been relatively spared from the devastating consequences of this infection. Neurologic involvement is being increasingly recognized among adults with COVID-19, who can develop sensory deficits in smell and taste, delirium, encephalopathy, headaches, strokes, and peripheral nervous system disorders. Among neonates and children, COVID-19-associated neurological manifestations have been relatively rare, yet reports involving neurologic dysfunction in this age range are increasing.

COVID-19 Neurologic involvement

Schematic showing possible CNS entry points and effects of SARS-CoV-2. The SARS-CoV-2 virus attaches to olfactory epithelium using the ACE-2 receptor. After cell entry, the virus replicates and induces a massive immune response leading to excessive cytokine release, comprising a maladaptive immune response. Theoretically, virus particles may reach the CNS retrogradely via cranial nerve pathways: V from corneal epithelium or oropharyngeal cutaneous sensory receptors; I via the cribiform plate, infecting olfactory sensory neurons; VII and IX from tongue chemoreceptors; X via pulmonary mechanoreceptors. Once reaching CNS nuclei including brainstem and cortex, a variety of neurologic signs and symptoms are possible. However, it must be noted that the virus has not been recovered from CSF or brain tissue, making all of these pathways hypothetical at this point. Abbreviations: NP, nasopharynx; GI, gastrointestinal; ACE-2, angiotensin converting enzyme type 2 receptor; PNS, peripheral nervous system; CNS, central nervous system; ICH, intracranial hemorrhage; GBS, Guillain-Barre syndrome; BBB, blood-brain barrier.


Subjects: Clinical Neurology
Contributors MDPI registered users' name will be linked to their SciProfiles pages. To register with us, please refer to : ,
View Times: 711
Revisions: 3 times (View History)
Update Date: 06 Nov 2020